Terminal differentiation of human erythroleukemia cell line K562 induced by aphidicolin

Takashi Murate, Yoshitoyo Kagami, Tomomitsu Hotta, Tomoaki Yoshida, Hidehiko Saito, Shonen Yoshida

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


To analyze the relationship between differentiation and DNA replication, the effect of aphidicolin, a specific inhibitor for DNA polymerase α, was measured with respect to erythroid differentiation and activities of DNA polymerases α,β, and γ. Five micromolar aphidicolin completely blocked the growth of K562 cells and caused 80% of cells to become hemoglobin positive after 5 days exposure. The cessation of K562 cell growth induced by aphidicolin was irreversible, whereas the inhibition of HeLa cell growth was completely reversible. The enzyme activity of DNA polymerase α of K562 cells showed a 50-110% increase with aphidicolin treatment as compared to control K562 cells; activities of DNA polymerases β and γ were not affected. These features sharply contrasted with the erythroid induction of the same cells by hemin, where cell growth was not suppressed and DNA polymerase α was not increased but rather decreased. The enzyme activity of DNA polymerase α remained high even after removal of aphidicolin from the culture medium. These results suggest that treatment with aphidicolin might induce an accumulation of protein factors for replication and/or differentiation, causing rapid cell differentiation of cells without Cell division.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalExperimental Cell Research
Issue number1
Publication statusPublished - 11-1990
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cell Biology


Dive into the research topics of 'Terminal differentiation of human erythroleukemia cell line K562 induced by aphidicolin'. Together they form a unique fingerprint.

Cite this